UNSPSC 51281503: Amithiozone or thiacetazone

This classification denotes an antitubercular agent with the molecular formula C10H12N4OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MMG78X7SSR, chemically known as acetanilide, 4-formyl-, thiosemicarbazone but generally known as amithiozone, which bears US NIH Compound Identifier 2733749. Amithiozone most often comes in base and thiacetazone forms. The term AMITHIOZONE is an International Non-Proprietary Name. Amithiozone or thiacetazone bears US NLM identifiers UMLS ID C0878231 and NCI Concept Code C90769.

SMILES: CC(=O)NC1=CC=C(C=C1)C=NNC(=S)N.

UNSPSC 51281503 Amithiozone or thiacetazone is a Commodity code that, based on recent state and local solicitations, does not reflect the actual purchasing activity tagged to it. The recent opportunities record shows that state and local governments are using this code to procure broad categories of medical and pharmaceutical products—naloxone and drug deactivation systems, generic multi-source pharmaceuticals and over-the-counter products, and medical and first aid supplies for emergency response—rather than the specific tuberculostatic drug named in the code. Issuing bodies include county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances serving multiple state and local members (Minnesota Multistate Cooperative Purchasing Alliance). The mismatch between the code name and the actual procurement scope suggests either a tagging error in the source data or a state and local practice of using a narrow commodity code as a container for broader pharmaceutical and medical-supply acquisitions.

Recent activity appears across Florida, Texas, Minnesota, and Oregon. Representative opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building (due July 26, 2026); the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, an estimated $700,000 contract sheltered for certified Small Local Business Enterprises with a 5% bid discount (due March 13, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products to be distributed across state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission also issued an RFI on direct-to-manufacturer prescription programs (due April 3, 2026) to inform future procurement strategy. Given the divergence between code name and actual scope, this code warrants clarification before pursuing opportunities listed under it.